Calamos Advisors »

Ani Pharmaceuticals shares owned by Calamos Advisors

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $41k 29k 1.41

More positions owned by Calamos Advisors

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Western Digital Corp Note 3.000%11/1 (Principal)
Visa Com Cl A (V)
Boeing Dep Conv Pfd A (BA.PA)

View all positions for Calamos Advisors

Top funds holding Ani Pharmaceuticals

Linden Advisors
Camden Asset Management
BlackRock
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
Jpmorgan Chase & Co
Lazard Asset Management
Polar Securities
Universal- Beteiligungs- und Servicegesellschaft mbH
Gabelli Funds
Leucadia National Corporation
Picton Mahoney Asset Management
FMR

View all funds holding Ani Pharmaceuticals